1 Capizzi BL, Bertion JR, Skeel RT, Creasey WA, Zanes R, Olayon C, et al. L-Asparaginase:Clinical, Biochemical, Pharmacological and Immunological Studies[J].Ann Intern Med, 1971;74(6):893-901 2 Fuertgets F, Abuchowski A.The clinical efficacy of poly(ethylene glycol)-modified proteins[J].J Control Release, 1990;11(1):139-48 3 吴敬, 赖龙生, 刘景晶, 吴梧桐.重组L-门冬酰胺的提取纯化工艺[J].中国医药工业杂志, 2000;31(2):50-3 4 Peterson RE, Ciegler A.L-asparaginase production by various bacteria[J].ApplMicrobiol, 1969;17(6):929-30 5 徐秀兰.生物化学实验与指导[M].北京:中国医药科技出版社, 1994:64-6 6 Guo QL, WU MS, Chen Z.Compairsion of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo[J].Acta Pharmacol Sin, 2002;23(10):946-51 7 曹荣月, 钱之玉, 胡燕, 刘飞键, 叶家辉, 刘景晶.聚乙二醇化学修饰的重组L-门冬酰胺酶抗肿瘤作用[C].2003年生化药学与多糖类药物国际研讨会(南京)论文集,2003:422-6 8 Lisa MH.Pegaspargase:an alternative[J]?Ann Pharmacother, 1997;31(5):616-23 9 Avranmis VI, Sencer S, Periclou AP, Sather H, Bostrom BC, Cohen LJ, et al.A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia:a children's cancer group study[J].Blood, 2002;99(6):1986-94 10 Kamisaki Y, Wada H, Yagura T, Matsushima A, Inada Y. Reduction in immunogenicity and cleance rate of Escherichia coli L-Asparaginase by Modification with Monomethoxypolyethylene Glycol[J].J pharmacol exp ther, 1981;216:410-4 11 ENZON.Oncaspar [EB OL].http: www.rxlist.com cgi generic2 pegaspargase.htm2003-12-31 12 周笑艳, 刘景晶.聚乙二醇对大肠杆菌L-天冬酰胺酶的化学修饰[J].中国药科大学学报, 2000, 31(3):230-3 |